You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CLOPIDOGREL BISULFATE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Clopidogrel Bisulfate, and what generic alternatives are available?

Clopidogrel Bisulfate is a drug marketed by Accord Hlthcare, Acme Labs, Actavis Totowa, Alkem Labs Ltd, Amneal Pharms, Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Dr Reddys, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Macleods Pharms Ltd, MSN, Polygen Pharms, Prinston Inc, Rising, Sciegen Pharms Inc, Sun Pharm, Sun Pharm Industries, Teva, Torrent Pharms Ltd, and Zydus Lifesciences. and is included in twenty-five NDAs.

The generic ingredient in CLOPIDOGREL BISULFATE is clopidogrel bisulfate. There are fifty-four drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Clopidogrel Bisulfate

A generic version of CLOPIDOGREL BISULFATE was approved as clopidogrel bisulfate by DR REDDYS on January 14^th, 2008.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CLOPIDOGREL BISULFATE?
What are the global sales for CLOPIDOGREL BISULFATE?
What is Average Wholesale Price for CLOPIDOGREL BISULFATE?

Summary for CLOPIDOGREL BISULFATE

US Patents:	0
Applicants:	23
NDAs:	25
Finished Product Suppliers / Packagers:	41
Raw Ingredient (Bulk) Api Vendors:	126
Clinical Trials:	19
Patent Applications:	3,476
Drug Prices:	Drug price information for CLOPIDOGREL BISULFATE
Drug Sales Revenues:	Drug sales revenues for CLOPIDOGREL BISULFATE
DailyMed Link:	CLOPIDOGREL BISULFATE at DailyMed

Drug patent expirations by year for CLOPIDOGREL BISULFATE

Drug Prices for CLOPIDOGREL BISULFATE

Recent Clinical Trials for CLOPIDOGREL BISULFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Joint Stock Company "Farmak"	Phase 1
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	N/A
Nanjing First Hospital, Nanjing Medical University	Phase 4

See all CLOPIDOGREL BISULFATE clinical trials

Pharmacology for CLOPIDOGREL BISULFATE

Drug Class	P2Y12 Platelet Inhibitor
Mechanism of Action	Cytochrome P450 2C8 Inhibitors P2Y12 Receptor Antagonists
Physiological Effect	Decreased Platelet Aggregation

Anatomical Therapeutic Chemical (ATC) Classes for CLOPIDOGREL BISULFATE

B01AC	Platelet aggregation inhibitors excl. heparin
B01A	ANTITHROMBOTIC AGENTS
B01	ANTITHROMBOTIC AGENTS
B	Blood and blood forming organs

Paragraph IV (Patent) Challenges for CLOPIDOGREL BISULFATE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
PLAVIX	Tablets	clopidogrel bisulfate	300 mg	020839	1	2009-03-04

US Patents and Regulatory Information for CLOPIDOGREL BISULFATE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	076999-001	May 17, 2012	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sciegen Pharms Inc	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	204165-001	Sep 15, 2014	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Torrent Pharms Ltd	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	090844-001	May 17, 2012	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sciegen Pharms Inc	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	204165-002	Sep 15, 2014	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Accord Hlthcare	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	202925-001	Mar 27, 2013		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd V	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	205345-002	Aug 4, 2023	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Prinston Inc	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	206376-002	May 7, 2018	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.